Troy E. Wilson - Jan 24, 2024 Form 4 Insider Report for Kura Oncology, Inc. (KURA)

Role
President and CEO, Director
Signature
Teresa Bair, Attorney-in-fact for Troy E. Wilson
Stock symbol
KURA
Transactions as of
Jan 24, 2024
Transactions value $
-$1,291,388
Form type
4
Date filed
1/26/2024, 05:10 PM
Previous filing
Jan 4, 2024
Next filing
Jun 14, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction KURA Common Stock Options Exercise $33.3K +6.95K +1242.4% $4.80 7.5K Jan 24, 2024 Direct F1
transaction KURA Common Stock Sale -$140K -6.95K -92.55% $20.23 559 Jan 24, 2024 Direct F1
transaction KURA Common Stock Options Exercise $517K +84.1K +15045.97% $6.15 84.7K Jan 24, 2024 Direct F1
transaction KURA Common Stock Sale -$1.7M -84.1K -99.34% $20.23 559 Jan 24, 2024 Direct F1
holding KURA Common Stock 300K Jan 24, 2024 by Lorax Charitable Remainder Unitrust
holding KURA Common Stock 279K Jan 24, 2024 by One Fish Two Fish Revocable Trust
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 20, 2022.